4//SEC Filing
Bensen Daniel 4
Accession 0001193125-26-016651
CIK 0001863127other
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 4:30 PM ET
Size
6.7 KB
Accession
0001193125-26-016651
Insider Transaction Report
Form 4
Bensen Daniel
Chief Discovery Officer
Transactions
- Sale
Common Stock
[F1][F2]2026-01-12$28.44/sh−6,983$198,610→ 155,998 total - Sale
Common Stock
[F1][F3]2026-01-12$29.08/sh−1,017$29,575→ 154,981 total
Footnotes (3)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024.
- [F2]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $27.9083 to $28.84. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- [F3]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $28.9131 to $29.23. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Signature
/s/ Ali D. Fawaz, Attorney-in-Fact|2026-01-20
Documents
Issuer
Tyra Biosciences, Inc.
CIK 0001863127
Entity typeother
Related Parties
1- filerCIK 0001880946
Filing Metadata
- Form type
- 4
- Filed
- Jan 19, 7:00 PM ET
- Accepted
- Jan 20, 4:30 PM ET
- Size
- 6.7 KB